| Lyumjev (insulin lispro-aabc injection) / Eli Lilly |
2022-001373-31: Ultrarapid insulin for the artificial pancreas Ultrasnelle insuline voor de kunstmatige alvleesklier |
|
|
| Not yet recruiting | 4 | 12 | Europe | Lyumjev, A10AB04, Lyumjev | Inreda Diabetic B.V., Inreda Diabetic B.V. | Type 1 diabetes mellitus Type 1 diabetes mellitus, Diabetes type 1 Suikerziekte type 1, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
NCT06370715: A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India |
|
|
| Recruiting | 4 | 112 | RoW | Insulin Lispro-aabc, LY900014, Insulin Glargine | Eli Lilly and Company, Cipla Ltd. | Diabetes Mellitus, Type 2 | 10/25 | 10/25 | | |
| Not yet recruiting | 4 | 50 | RoW | Ultra Rapid Lispro (URLi), Lyumjev, Insulin pump with continuous glucose monitoring (CGM), MiniMed 780G Hybrid Closed-Loop System | Tel-Aviv Sourasky Medical Center | Type 1 Diabetes (T1D) | 09/25 | 10/25 | | |
2017-003399-30: A study to compare an investigational ultra-rapid insulin, LY900014 with another mealtime insulin, Fiasp when both are used along with a long-acting insulin in people with type 1 diabetes |
|
|
| Ongoing | 3 | 632 | Europe | ultra-rapid formulation of insulin lispro, Fiasp®, LY900014, Solution for injection, Fiasp® | Eli Lilly and Company, Lilly S.A., Eli Lilly and Company | Diabetes Mellitus, Type 1, Diabetes, Diseases [C] - Hormonal diseases [C19] | | | | |
FCL, NCT06046417: A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes |
|
|
| Recruiting | 2/3 | 30 | Canada | Pramlintide, Lyumjev, Automated Insulin Delivery (AID) system | McGill University Health Centre/Research Institute of the McGill University Health Centre, Juvenile Diabetes Research Foundation | type1diabetes, Diabetes Mellitus, Type 1 | 04/25 | 06/25 | | |
Lilly-MEALS, NCT06021158: A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes |
|
|
| Recruiting | 2 | 12 | Canada | Hybrid automated Lyumjev delivery system with carbohydrate counting, Hybrid automated Lyumjev delivery system with meal size estimation, Fully automated Lyumjev delivery system with meal detection | McGill University Health Centre/Research Institute of the McGill University Health Centre | Diabetes Mellitus, Type 1, Type 1 Diabetes | 12/24 | 12/24 | | |
| Not yet recruiting | 1/2 | 30 | NA | Lyumjev 100 UNT/ML Injectable Solution, Lyumjev, Premixed Lyumjev | St. Olavs Hospital, Norwegian University of Science and Technology | Type 1 Diabetes | 07/25 | 12/25 | | |
NCT05262387: A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes |
|
|
| Completed | 1 | 25 | Canada | Lyumjev with 50% basal rate reduction, LY900014, Humalog with 50% basal rate reduction, Insulin Lispro, Humalog with 100% basal rate reduction, Lyumjev with 100% basal rate reduction | Eli Lilly and Company | Diabetes Mellitus, Type 1 | 03/23 | 03/23 | | |
| Completed | N/A | 12 | Europe | Insulin Lispro Cartridge [Lyumjev], Lyumjev, Insulin Lispro Cartridge, Humalog | Inreda Diabetic B.V., Inreda Diabetic B.V. | Type 1 Diabetes | 03/23 | 03/23 | | |
NCT05403502: Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes |
|
|
| Completed | N/A | 183 | US | t:slim X2 insulin pump with Control-IQ technology 1.5 | Tandem Diabetes Care, Inc., Eli Lilly and Company, Jaeb Center for Health Research | Type 1 Diabetes | 08/23 | 08/23 | | |
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev® |
|
|
| Completed | N/A | 244 | US | MiniMed 780G System | Medtronic Diabetes, Eli Lilly and Company | Type 1 Diabetes | 01/24 | 01/24 | | |
ACOLYTE, NCT05660941: Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro ( Study) |
|
|
| Recruiting | N/A | 26 | Europe | Lispro, Lyumjev, Humalog | Manchester University NHS Foundation Trust | Diabetes Mellitus, Type 1 | 05/24 | 05/24 | | |
